Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$7,922,885
+$608,697 QoQ
Shares Held
31,485
-6.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#1,038
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oliver Luxxe Assets LLC holds $24,335,082 across 7 Drug Manufacturers - General names. ABBV ranks #2 (32.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
45,272 | $8,584,476 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
31,485 | $7,922,885 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
52,852 | $6,677,321 | |
| 4 | PFE |
Pfizer Inc
|
18,762 | $451,788 | |
| 5 | JNJ |
Johnson & Johnson
|
1,059 | $268,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 | |
| 7 | AMGN |
Amgen Inc
|
590 | $213,650 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,922,885 | 31,485 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $7,314,188 | 33,630 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $9,422,699 | 41,239 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $9,456,556 | 40,842 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $7,113,886 | 38,325 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $7,694,831 | 36,726 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,599,422 | 37,138 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $7,244,948 | 36,687 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $6,376,942 | 37,179 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,765,379 | 37,152 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $5,802,851 | 37,445 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,548,162 | 37,221 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,943,513 | 36,692 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $5,883,143 | 36,915 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $6,458,258 | 39,962 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $5,364,373 | 39,970 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,023,170 | 39,326 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,275,926 | 38,714 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,489,793 | 40,545 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $4,373,589 | 40,545 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,129,157 | 36,658 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,640,520 | 33,640 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,188,784 | 29,760 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,935,301 | 22,095 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,813,875 | 18,475 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,335,229 | 17,525 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||